Kairos Pharma, LTD. (KAPA) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-21 | 8-K | Item 3.03, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-22 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-30 | 8-K | Shareholder Vote Results | SEC |
| 2026-06-04 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-02 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-26 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-10-07 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-12 | 8-K | Material Agreement, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-06-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-04-28 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-04-24 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-26 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-17 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-01-14 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-12-13 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-11-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-10 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-04 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-27 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-24 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-17 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.